Learn More
Medchemexpress LLC IRAK4-IN-7 | 1801343-74-7 | 99.4% | 417.42 | 200 UG

Supplier: Medchemexpress LLC HY10958510MM/1ML
IRAK4-IN-7 is a selective, potent, and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor. It is extracted from patent WO2015104688 (example 1) and holds potential for the treatment of cancer and inflammatory diseases. It exhibits anti-cancer and anti-inflammatory activities, making it suitable for research in these therapeutic areas.
- Selective and potent inhibitor
- Orally active
- Potential for cancer treatment
- Potential for inflammatory diseases treatment
- Suitable for in vivo and in vitro research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.